Meghmani Organics Ltd Hits All-Time Low Amid Continued Downtrend

Stock Performance and Market Context

On 24 Feb 2026, Meghmani Organics Ltd recorded its lowest-ever price at Rs.50.83, continuing a downward trajectory that has seen the stock fall for five consecutive days, accumulating a loss of 5.33% over this period. This recent decline outpaces the sector’s underperformance by 0.4% on the same day, with the stock dropping 0.86% compared to the Sensex’s 0.79% fall.

Over longer time frames, the stock’s underperformance is more pronounced. The one-week return stands at -5.73% versus the Sensex’s -0.98%, while the one-month return is -8.98% against a positive 1.35% for the Sensex. The three-month performance shows a steep decline of -24.78%, significantly worse than the Sensex’s -2.67%. Over the past year, Meghmani Organics has delivered a negative return of -27.96%, contrasting sharply with the Sensex’s 10.99% gain. Year-to-date figures also highlight a -21.00% return against the Sensex’s -3.03%.

The stock’s longer-term performance further emphasises its challenges. Over three years, it has lost 45.88%, while the Sensex has appreciated by 38.97%. The five- and ten-year returns for Meghmani Organics remain flat at 0.00%, whereas the Sensex has surged by 62.73% and 257.91%, respectively.

Meghmani Organics is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, underscoring the sustained bearish momentum.

Financial Metrics and Profitability Analysis

Meghmani Organics’ financial indicators reveal considerable strain. The company’s operating profits have declined at a compound annual growth rate (CAGR) of -17.31% over the last five years, signalling weakening core earnings capacity. This deterioration is reflected in the company’s Mojo Score of 14.0 and a downgrade in its Mojo Grade from Sell to Strong Sell as of 1 Jan 2026.

Profitability metrics remain subdued, with an average Return on Equity (ROE) of 6.03%, indicating limited returns generated per unit of shareholders’ funds. The Return on Capital Employed (ROCE) stands at 4.6%, which, while modest, is accompanied by an attractive valuation metric of 0.9 for Enterprise Value to Capital Employed, suggesting the stock is trading at a discount relative to its capital base.

Quarterly performance data further highlights challenges. The Profit After Tax (PAT) for the latest quarter was negative at Rs. -3.53 crores, a sharp fall of 135.6% compared to the previous four-quarter average. Interest expenses have increased by 22.18% over nine months, reaching Rs. 71.38 crores, exerting additional pressure on earnings. The operating profit to interest coverage ratio for the quarter is at a low 2.08 times, underscoring the company’s constrained ability to service debt obligations.

Market Position and Shareholder Composition

Despite its size within the Pesticides & Agrochemicals sector, Meghmani Organics has negligible domestic mutual fund ownership, with funds holding 0% of the company. Given that domestic mutual funds typically conduct thorough research and maintain stakes in companies with favourable prospects, this absence may reflect reservations about the company’s current valuation or business outlook.

The stock’s consistent underperformance against benchmarks is notable. It has lagged behind the BSE500 index in each of the last three annual periods, reinforcing the trend of subpar returns relative to the broader market.

Interestingly, while the stock has generated a negative return of -27.96% over the past year, the company’s profits have risen by 183.8% during the same period. This divergence is reflected in a low Price/Earnings to Growth (PEG) ratio of 0.2, indicating that the market valuation does not currently reflect the recent profit growth.

Sector and Valuation Considerations

Operating within the Pesticides & Agrochemicals sector, Meghmani Organics faces a competitive environment where valuation metrics are critical. The company’s current Enterprise Value to Capital Employed ratio of 0.9 is below the average historical valuations of its peers, suggesting the stock is trading at a discount. However, this valuation discount accompanies a backdrop of weak long-term fundamentals and subdued profitability metrics.

The company’s Mojo Grade of Strong Sell, combined with a Market Cap Grade of 3, reflects the market’s cautious stance. The downgrade from Sell to Strong Sell on 1 Jan 2026 highlights the deteriorating outlook as assessed by comprehensive scoring methodologies.

Meghmani Organics’ recent share price movements and financial results illustrate a complex picture of valuation disconnects and persistent challenges. The stock’s sustained underperformance relative to the Sensex and sector benchmarks over multiple time horizons emphasises the severity of its current position.

Summary of Key Financial Indicators

Operating Profit CAGR (5 years): -17.31%

Average EBIT to Interest Ratio: -5.58

Average Return on Equity: 6.03%

Latest Quarterly PAT: Rs. -3.53 crores (down 135.6%)

Interest Expense (9 months): Rs. 71.38 crores (up 22.18%)

Operating Profit to Interest Coverage (Quarter): 2.08 times

Mojo Score: 14.0

Mojo Grade: Strong Sell (downgraded from Sell on 1 Jan 2026)

Market Cap Grade: 3

Concluding Observations

Meghmani Organics Ltd’s fall to an all-time low price of Rs.50.83 marks a significant event in its market journey, underscored by a prolonged period of underperformance and challenging financial metrics. The stock’s consistent lag behind the Sensex and sector indices, combined with weak profitability and debt servicing ratios, paints a detailed picture of the company’s current standing within the Pesticides & Agrochemicals sector.

While valuation metrics suggest the stock is trading at a discount relative to peers, the broader financial and market data indicate a cautious environment for Meghmani Organics. The company’s Mojo Grade of Strong Sell and the absence of domestic mutual fund holdings further reflect the prevailing market sentiment.

Investors and market participants will continue to monitor Meghmani Organics’ performance closely as it navigates this challenging phase.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →